Saturday, October 29, 2016
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that the U.S. Food and Drug Administration has cleared its VITROS® Automation Solutions for use with Ortho’s VITROS® Chemistry, Immunodiagnostics and Integrated Systems, allowing U.S. clinical laboratories using VITROS® Automation Solutions to improve results throughout every phase of diagnostic testing, now and into the future. VITROS® Automation Solutions will be available for purchase in the U.S. starting October 2016.
VITROS® Automation Solutions is an open platform – both expandable and adaptive – that provides laboratory clinicians the flexibility to run and grow their labs in exactly the manner that works best for them, even as needs change over time.
“VITROS® Automation Solutions gives us the flexibility to cope with low and high peak capacity,” said Dr. Giovanni Garozzo, director of the Transfusion Centres of ASP Ragusa, Italy.
“VITROS® Automation Solutions is Ortho’s answer to the limitations of past automation systems,” said Robert Yates, chief operating officer at Ortho. “Through its flexibility, scalability and start-to-finish automation capability, our next-generation VITROS® Automation Solutions platform puts high-volume laboratory clinicians in total control of their facilities.”
Capabilities of VITROS® Automation Solutions’ include:
• Open Connectivity
Enables labs to connect to third-party analyzers that complement VITROS Automation Solutions in disciplines such as coagulation and hematology, as well as to select immunoassay platforms that broaden menu coverage
• Flexible Data Management using Instrument Manager™
Allows labs to configure solutions that address their specific needs
Provides necessary flexibility for adaption to a fast-changing environment
• Refrigerated Storage
Simplifies and automates post-analytical sample processing using this on-line storage module, which allows for up to 14,000 samples to be archived and retrieved for re-testing -- a critical requirement for high-volume laboratories seeking to increase productivity and reduce errors.
The improvement in control has impact across operations, performance and quality. VITROS® Automation Solutions’ Thermo Scientific™ TCAutomation™ allows laboratories to define capabilities over time for optimal efficiencies. IMSolutions™ for VITROS® Automation Solutions delivers fast results, instant access to timely, actionable performance metrics, and minimal disruption with pre-written auto-verification rules. Ortho’s proprietary Intellicheck™ Technology gives real-time process control that protects the integrity of results. Additionally, with Ortho’s e-Connectivity® Remote Diagnostics Management, instrument performance is continuously tracked, helping to identify specific service needs up to 30 days in advance, and to improve instrument uptime.
Designed to be easily scalable, VITROS® Automation Solutions platform allows for stepwise investment, which lets laboratories grow as their needs do and as new modules become available. It also allows skilled technicians to focus on higher value-added tasks that truly require human interaction. Automation technology also reduces errors and turnaround times. The net effect is a more cost-efficient workplace and improved patient care.
Source : orthoclinical.com
